UK Public Sector Contracts & Tenders

Cell Therapy Catapult Ltd is seeking to contract with a suitably capable Bidder to provide the Services for the ribosome profiling of suspension-adapted human cells producing an adeno-associated virus (AAV) vector. The supplier will need to perform laboratory experiments and data analysis. If you are interested in this opportunity please access the tender documents via the link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

Integration and adaptation of the new operational excellence programme with the programme that currently exists. We are looking to continue with an Operational Excellence Programme on a wider scale, at different CGTC sites. To access the procurement documents, please use the link below: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

We are looking to continue an Operational Excellence Programme on a wider scale, at different CGTC sites. The Operational Excellence initiative is being established to ensure that the business can function in a high performing high-quality state across all main business streams: Stevenage Manufacturing and Innovation Centre, Braintree Manufacturing and Innovation Centre, London Research and Development (Technology, Process and Innovation), and Business Services. The aim is to ensure advanced therapies are developed and delivered to patients rapidly and efficiently at a high standard of quality and with a sustainable business model. If you are interested, please use the following link to access the procurement documents: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

CGTC are looking for consultants to design and develop a laboratory for advanced therapy medicinal products (ATMPs) that meets the principles of Universal Design (UD) and can be scaled-out across the sector. If you are interested in this opportunity please access the procurement document through our organisations E-tendering Portal, via the following link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

Cell Therapy Catapult Ltd is seeking through this Open Tender Process to contract with a suitably capable Bidder to provide the Services for the untargeted metabolomics of cell-free media from suspension-adapted cells producing adeno-associated viral vectors (AAV). Briefly, human cells will be subjected to AAV production in parallel with controls. A maximum of 35 sample and two medium controls will be generated in this experiment, designated as "Run 1", and sent to the awarded Bidder each as technical replicates (maximum 3 per sample). The samples will then be processed by the awarded Bidder as per requirements detailed in Specification (Appendix B). In addition to "Run 1", two additional runs ("Run 2" and "Run 3") may be performed at our sole discretion. Importantly, the experimental setup for both "Run 2" and "Run 3" will be similar to that for "Run 1", but sample numbers may differ if additional conditions are included or excluded. A maximum of 37 samples (i.e., including medium controls) will be obtained for either "Run 2" and "Run 3". Subsequent runs or analysis may be performed, contingent on the results obtained from the 3 planned runs. This will be to ensure robustness of the findings or to meet unforeseen project needs. This will be based on satisfactory performance and continued need.

Cell Therapy Catapult Ltd is seeking through this Open tender process to contract with a specialist provider of customer surveys / customer feedback and with experience of research and technology organisations in the healthcare industries. The supplier will be responsible for collecting and analysing the data produced by the surveys and collating it into an acceptable format to report back to CGT Catapult. If you would like to access the procurement documents please use this link: https://catapultcgtc.wax-live.com/S2C/DisplayModules/TradeModules/Negotiations/Opportunities/ListEvents.aspx?ApplicationInstanceID=27adc89e-0cb2-4b51-9bc1-34061f10156f

Report Writing and Data Analysis Description: The ATTC programme is seeking for organisations and/or independent consultants to provide report writing and data analysis services in relation the outputs of milestones within the 7 workstreams of the Phase 2 Delivery plan. The overall aim is to manage the outputs of the work performed under the Programme in an effective and efficient way that promotes quality, unbiased interpretation of milestone results, and excellent communication that fully comprehends the methodologies that will be applied. The requirement for this service has been identified since funding from the NIHR, Innovate UK was provided, and CGT Catapult was tasked with coordinating the network. This requirement has been clearly identified within the delivery plan and approved by all the relevant bodies as key outputs of key milestones. These reports will not only demonstrate the impact of the work that is being carried out under the Phase 2 programme, but it enables for UK-wide distribution and familiarisation of key initiatives thereby pointing back to the overarching programme goal - Expand and embed the ATTC Network as a sustainable model within the NHS/NIHR to enable equitable and timely access to Advanced Therapies trials. The programme will be run across 4 years with the first report targeted for Mar 2025. There will be reports producible annually and reports produced as determined by the timelines of milestones.